Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria

Abstract Conjugated fatty acids (CFAs) have been known for their anti-tumor activity. However, the mechanism of action remains unclear. Here, we identify CFAs as inducers of glutathione peroxidase 4 (GPX4) degradation through chaperone-mediated autophagy (CMA). CFAs, such as (10E,12Z)-octadecadienoi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuke Hirata, Yuto Yamada, Soma Taguchi, Ryota Kojima, Haruka Masumoto, Shinnosuke Kimura, Takuya Niijima, Takashi Toyama, Ryoji Kise, Emiko Sato, Yasunori Uchida, Junya Ito, Kiyotaka Nakagawa, Tomohiko Taguchi, Asuka Inoue, Yoshiro Saito, Takuya Noguchi, Atsushi Matsuzawa
Format: Article
Language:English
Published: Nature Publishing Group 2024-12-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07237-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136738977677312
author Yusuke Hirata
Yuto Yamada
Soma Taguchi
Ryota Kojima
Haruka Masumoto
Shinnosuke Kimura
Takuya Niijima
Takashi Toyama
Ryoji Kise
Emiko Sato
Yasunori Uchida
Junya Ito
Kiyotaka Nakagawa
Tomohiko Taguchi
Asuka Inoue
Yoshiro Saito
Takuya Noguchi
Atsushi Matsuzawa
author_facet Yusuke Hirata
Yuto Yamada
Soma Taguchi
Ryota Kojima
Haruka Masumoto
Shinnosuke Kimura
Takuya Niijima
Takashi Toyama
Ryoji Kise
Emiko Sato
Yasunori Uchida
Junya Ito
Kiyotaka Nakagawa
Tomohiko Taguchi
Asuka Inoue
Yoshiro Saito
Takuya Noguchi
Atsushi Matsuzawa
author_sort Yusuke Hirata
collection DOAJ
description Abstract Conjugated fatty acids (CFAs) have been known for their anti-tumor activity. However, the mechanism of action remains unclear. Here, we identify CFAs as inducers of glutathione peroxidase 4 (GPX4) degradation through chaperone-mediated autophagy (CMA). CFAs, such as (10E,12Z)-octadecadienoic acid and α-eleostearic acid (ESA), induced GPX4 degradation, generation of mitochondrial reactive oxygen species (ROS) and lipid peroxides, and ultimately ferroptosis in cancer cell lines, including HT1080 and A549 cells, which were suppressed by either pharmacological blockade of CMA or genetic deletion of LAMP2A, a crucial molecule for CMA. Mitochondrial ROS were sufficient and necessary for CMA-dependent GPX4 degradation. Oral administration of an ESA-rich oil attenuated xenograft tumor growth of wild-type, but not that of LAMP2A-deficient HT1080 cells, accompanied by increased lipid peroxidation, GPX4 degradation and cell death. Our study establishes mitochondria as the key target of CFAs to trigger lipid peroxidation and GPX4 degradation, providing insight into ferroptosis-based cancer therapy.
format Article
id doaj-art-03c5af266e5e42b0a6a6c297d28bbde4
institution Kabale University
issn 2041-4889
language English
publishDate 2024-12-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-03c5af266e5e42b0a6a6c297d28bbde42024-12-08T12:47:28ZengNature Publishing GroupCell Death and Disease2041-48892024-12-01151211510.1038/s41419-024-07237-wConjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondriaYusuke Hirata0Yuto Yamada1Soma Taguchi2Ryota Kojima3Haruka Masumoto4Shinnosuke Kimura5Takuya Niijima6Takashi Toyama7Ryoji Kise8Emiko Sato9Yasunori Uchida10Junya Ito11Kiyotaka Nakagawa12Tomohiko Taguchi13Asuka Inoue14Yoshiro Saito15Takuya Noguchi16Atsushi Matsuzawa17Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityDivision of Clinical Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Organelle Pathophysiology, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku UniversityLaboratory of Food Function Analysis, Graduate School of Agricultural Sciences, Tohoku UniversityLaboratory of Food Function Analysis, Graduate School of Agricultural Sciences, Tohoku UniversityLaboratory of Organelle Pathophysiology, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku UniversityLaboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityLaboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku UniversityAbstract Conjugated fatty acids (CFAs) have been known for their anti-tumor activity. However, the mechanism of action remains unclear. Here, we identify CFAs as inducers of glutathione peroxidase 4 (GPX4) degradation through chaperone-mediated autophagy (CMA). CFAs, such as (10E,12Z)-octadecadienoic acid and α-eleostearic acid (ESA), induced GPX4 degradation, generation of mitochondrial reactive oxygen species (ROS) and lipid peroxides, and ultimately ferroptosis in cancer cell lines, including HT1080 and A549 cells, which were suppressed by either pharmacological blockade of CMA or genetic deletion of LAMP2A, a crucial molecule for CMA. Mitochondrial ROS were sufficient and necessary for CMA-dependent GPX4 degradation. Oral administration of an ESA-rich oil attenuated xenograft tumor growth of wild-type, but not that of LAMP2A-deficient HT1080 cells, accompanied by increased lipid peroxidation, GPX4 degradation and cell death. Our study establishes mitochondria as the key target of CFAs to trigger lipid peroxidation and GPX4 degradation, providing insight into ferroptosis-based cancer therapy.https://doi.org/10.1038/s41419-024-07237-w
spellingShingle Yusuke Hirata
Yuto Yamada
Soma Taguchi
Ryota Kojima
Haruka Masumoto
Shinnosuke Kimura
Takuya Niijima
Takashi Toyama
Ryoji Kise
Emiko Sato
Yasunori Uchida
Junya Ito
Kiyotaka Nakagawa
Tomohiko Taguchi
Asuka Inoue
Yoshiro Saito
Takuya Noguchi
Atsushi Matsuzawa
Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
Cell Death and Disease
title Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
title_full Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
title_fullStr Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
title_full_unstemmed Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
title_short Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria
title_sort conjugated fatty acids drive ferroptosis through chaperone mediated autophagic degradation of gpx4 by targeting mitochondria
url https://doi.org/10.1038/s41419-024-07237-w
work_keys_str_mv AT yusukehirata conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT yutoyamada conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT somataguchi conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT ryotakojima conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT harukamasumoto conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT shinnosukekimura conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT takuyaniijima conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT takashitoyama conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT ryojikise conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT emikosato conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT yasunoriuchida conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT junyaito conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT kiyotakanakagawa conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT tomohikotaguchi conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT asukainoue conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT yoshirosaito conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT takuyanoguchi conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria
AT atsushimatsuzawa conjugatedfattyacidsdriveferroptosisthroughchaperonemediatedautophagicdegradationofgpx4bytargetingmitochondria